Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease

NCT02752191 is registered in ClinicalTrials.gov with Paul Finn as lead sponsor.

NCT NCT02752191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02752191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease
Lead sponsor
Paul Finn
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2016
Completion date
December 19, 2018
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric congenital heart disease